ZLNA ZELLUNA ASA

Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation

Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation

Oslo, Norway, 14 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, invites you to a webcast presentation of its second quarter 2025 results, on Wednesday, August 20, 2025.

The presentation can be followed as a live webcast accessed through a link on at 09:00 CET on Wednesday, August 20, 2025. The webcast presentation will be available on the Zelluna website, and it will be possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 07:00 CET the same day.

For further information, please see or contact:

For further information, please contact:

Namir Hassan, CEO, Zelluna ASA

Email: 

Phone:

Hans Vassgård Eid, CFO, Zelluna ASA

Email: 

Phone:



EN
14/08/2025

Underlying

ZLNAZELLUNA ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZELLUNA ASA

 PRESS RELEASE
Free
ZLNA ZELLUNA ASA

Zelluna ASA: Notice of extraordinary general meeting on 25 November 20...

Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 Oslo, 4 November 2025: Reference is made to the stock exchange notice published by Zelluna ASA (the "Company") on 3 November 2025 regarding the successful private placement and retail offering.  The Company's board of directors (the "Board") hereby calls for an extraordinary general meeting on 25 November 2025 at 09:00 CET (the "EGM") to resolve upon proposals by the Board to issue the new shares in tranche 2 of the private placement and to authorize the Board to issue new shares in a potential subsequent repair offer...

November 4, 2025 1 EN
 PRESS RELEASE
Free
ZLNA ZELLUNA ASA

Zelluna ASA: Disclosure of large shareholding

Zelluna ASA: Disclosure of large shareholding In accordance with the Norwegian Securities Trading Act Section 4-3, Inven2 AS ( “Inven2” ) hereby notifies that its ownership interest in Zelluna ASA (“Zelluna”) has fallen below the 10% threshold following the share capital increase in Zelluna through the private placement on November 3rd 2025. Previous shareholding : 10,79% New shareholding : 9,01% Total number of shares held: 2,207,034 The reduction in ownership is due to dilution as result of the private placement. Inven2 has not sold any shares. This notification is submitted pursu...

November 4, 2025 1 EN
 PRESS RELEASE
Free
ZLNA ZELLUNA ASA

Zelluna ASA: Disclosure of large shareholding

Zelluna ASA: Disclosure of large shareholding Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the allocation of 5,500,000 new shares in the Company in a private placement (the "Private Placement"), divided on a first tranche of 3,729,774 new shares ("Tranche 1") and a second tranche of 1,770,226 new shares, and the allocation of 315,639 new shares in a retail offering via the PrimaryBid Platform (the "Retail Offering").  Radforsk Investeringsstiftelse ("Radforsk") holds 2,469,693 shares in the Company, representing 12.07...

November 4, 2025 1 EN
 PRESS RELEASE
Free
ZLNA ZELLUNA ASA

Zelluna ASA – Ex. date

Zelluna ASA – Ex. date The shares in Zelluna ASA will from today, 4 November 2025, be traded exclusive of the right to participate in the contemplated subsequent offering announced on 3 November 2025. This information is published in accordance with the requirements of the Continuing Obligations for Euronext Oslo Børs.  

November 4, 2025 1 EN
 PRESS RELEASE
Free
ZLNA ZELLUNA ASA

Zelluna ASA – Key information relating to subsequent offering

Zelluna ASA – Key information relating to subsequent offering Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the allocation of 5,500,000 new shares in the Company in a private placement (the "Private Placement"), the allocation of 315,639 new shares in a retail offering via the PrimaryBid platform (the "PrimaryBid Offering"), and a potential subsequent repair offering of up to 800,000 new shares at the same subscription price as in the Private Placement and the PrimaryBid Offering (the "Subsequent Offering"). The Subsequ...

November 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch